Deferasirox - NDC Database (Page 4)
68462-494 Jan 06, 2020
Deferasirox 125 mg Oral Tablet, for Suspension by Glenmark Pharmaceuticals Inc., USA
Deferasirox 125 mg Oral Tablet, for Suspension by Glenmark Pharmaceuticals Inc., USA
68462-495 Jan 06, 2020
Deferasirox 250 mg Oral Tablet, for Suspension by Glenmark Pharmaceuticals Inc., USA
Deferasirox 250 mg Oral Tablet, for Suspension by Glenmark Pharmaceuticals Inc., USA
68462-496 Jan 06, 2020
Deferasirox 500 mg Oral Tablet, for Suspension by Glenmark Pharmaceuticals Inc., USA
Deferasirox 500 mg Oral Tablet, for Suspension by Glenmark Pharmaceuticals Inc., USA
69238-1487 Jun 15, 2020
Deferasirox 180 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
Deferasirox 180 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
69238-1488 Jan 02, 2020
Deferasirox 360 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
Deferasirox 360 mg Oral Tablet, Film Coated by Amneal Pharmaceuticals Ny LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.